Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Holmes, R.P.
Right arrow Articles by Soothill, P.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holmes, R.P.
Right arrow Articles by Soothill, P.W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 7, 1879-1884, July 1999
© 1999 European Society of Human Reproduction and Embryology

Maternal serum insulin-like growth factor binding protein-2 and -3 and fetal growth

R.P. Holmes1, J.M.P. Holly2 and P.W. Soothill1,3

1 Fetal Medicine Research Unit, University of Bristol, St Michael's Hospital, Southwell Street, Bristol BS2 8EG and 2 Department of Surgery, University of Bristol, Bristol Royal Infirmary, Marlborough Street, Bristol BS2, UK

This was a prospective observational study of maternal insulin-like growth factor binding protein-2 and -3 and fetal growth in 141 pregnant women after 24 weeks gestation who were scanned and venesected fortnightly. Cases (birthweight <5th centile) were sub-divided into those with growth restriction due to placental dysfunction (n = 25) and normal small (n = 27) and there were 89 normally grown controls. Maternal binding protein-3 was measured by radioimmunoassay and the overall pattern of the binding proteins and their proteolytic modifications were assessed by Western ligand blotting and immunoblotting followed by densitometric analysis. In controls, there was no correlation between binding protein-3 and birthweight, and binding protein-3 was elevated in the normal small but not the placental dysfunction group. Complete proteolysis of the 40 kDa doublet of binding protein-3 was observed in all pregnancies. Maternal serum binding protein-2 concentrations were unchanged in normal pregnancy compared to non-pregnant controls but elevated in the growth-restricted group and in all pregnancies binding protein-2 was predominantly present as a 14 kDa proteolysed fragment. These results suggest that compensatory changes in binding protein-2 and -3 or their proteolysis do not increase bioavailability and so do not confound the low maternal insulin-like growth factor-I in growth restricted pregnancies.

Key words: Doppler/fetal/growth/IGF/maternal

3 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. Troisi, N. Potischman, and R. N. Hoover
Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Baik, W. J. DeVito, K. Ballen, P. S. Becker, W. Okulicz, Q. Liu, E. Delpapa, P. Lagiou, S. Sturgeon, D. Trichopoulos, et al.
Association of Fetal Hormone Levels with Stem Cell Potential: Evidence for Early Life Roots of Human Cancer
Cancer Res., January 1, 2005; 65(1): 358 - 363.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. S. Boyne, M. Thame, F. I. Bennett, C. Osmond, J. P. Miell, and T. E. Forrester
The Relationship among Circulating Insulin-Like Growth Factor (IGF)-I, IGF-Binding Proteins-1 and -2, and Birth Anthropometry: A Prospective Study
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1687 - 1691.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.